Back to search
FDAFDA · Food and drugs·Recall number D-0391-2024

Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11

Published March 27, 2024 · Recall initiated: February 20, 2024

Summary

FDA records drug Class II recall D-0391-2024, published March 27, 2024 and initiated February 20, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 43,920 vials; Lot: Lot #: 3NC22019, Exp. Date 2/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

What to do

Voluntary: Firm initiated · Letter

Get an email if NICARDIPINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NICARDIPINE HYDROCHLORIDE
Manufacturer
Eugia US LLC
Distributor
Nationwide within the United States
UPC
0355150183111
Lot
Lot #: 3NC22019, Exp. Date 2/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11 recalled?

Yes. FDA published recall D-0391-2024 on March 27, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for organic impurities

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NICARDIPINE HYDROCHLORIDE. UPC: 0355150183111.